Table 3.
First author | Year of publ. | Cases for review | Cause of death | Major diagnoses | Minor diagnoses | |||||
---|---|---|---|---|---|---|---|---|---|---|
Agreement (95%CI) | Sensitivity (95%CI) | Agreement (95%CI) | Sensitivity (95%CI) | Agreement (95%CI) | Sensitivity (95%CI) | |||||
Non-invasive methods | Puranik [45] | 2014 | 11 | MRI: 11/11 = 100 % (71.5; 100) CT: 3/11 = 27.3 % (6.0; 61.0) |
MRI: 10/10 = 100 % (69.2; 100) CT: 2/10 = 20 % (2.5; 55.6) |
n/r | n/r | n/r | n/r | |
Roberts [37] | 2012 | 182 (-6)1 | ῍70 %῍ (62.6; 76.4) |
n/r | n/r | n/r | n/r | n/r | ||
Takahashi [38] | 2012 | 16 (-2)1 | 10/16 = 62.5 % (35.4; 84.8) |
8/14 = 57.1 % (28.9; 82.3) |
n/r | n/r | n/r | n/r | ||
Westphal [39] | 2012 | 24 | n/r | 17/24 = 70.8 %2 (48.9; 87.4) |
death related diagnoses 23/44 = 52.3 % (36.7; 67.5) |
death related diagnoses 23/43 = 53.5 % (37.7; 68.8) |
21/69 = 30.4 % (19.9; 42.7) |
21/45 = 46.7 % (31.7; 62.1) |
||
Wichmann [46] | 2012 | 47 | n/r | n/r | n/r |
new major diagnoses
10/14 = 71.4 % (41.9; 91.6) |
new minor diagnoses
26/88 = 29.5 % (20.3; 40.2) |
new minor diagnoses
26/61 = 42.6 % (30.0; 56.0) |
||
Roberts [47] | 2003 | 10 | n/r | 6/10 = 60 %2 (26.2; 87.8) |
n/r | n/r | n/r | n/r | ||
Patriquin [48] | 2001 | 7 | n/r | 3/7 = 42,9 %2 (9.9; 81.6) |
13/34 = 38.2 % (22.2; 56.4) death related diagnoses 6/15 = 40 % (16.3; 67.7) |
13/23 = 56.5 % (34.5; 76.8) death related diagnoses 6/11 = 54.5 % (23.4; 83.3) |
8/39 = 20.5 % (9.3; 36.5) |
8/23 = 34.8 % (16.4; 57.3) |
||
Minimally invasive methods | With radiological imaging | Wichmann [49] | 2014 | 50 | n/r | n/r |
new major diagnoses
13/16 = 81.3 % (54.4; 96.0) overall diagnoses 405/590 = 68.6 % (64.7; 72.4) |
new major diagnoses
13/14 = 92.9 % (66.1; 99.8) overall diagnoses 402/474 = 84.8 % (81.3; 87.9) |
new minor diagnoses
140/238 = 58.8 % (52.3; 65.1) |
new minor diagnoses
140/190 = 73.7 % (66.8; 79.8) |
Ross [43] | 2012 | 19* | n/r | 18/19 = 94.7 %2 (74.0; 99.9) |
n/r | n/r | n/r | n/r | ||
Bolliger [44] | 2010 | 19* | n/r | 17/19 = 89.5 %2 (66.9; 98.7) |
n/r | n/r | n/r | n/r | ||
Weustink [50] | 2009 | 30 | 23/30 = 76,7 % (57.7; 90.1) |
n/r | 129/140 = 92.1 % (86.4; 96.0) overall diagnoses 2019/2056 = 98.2 % (97.5; 98.7) |
129/137 = 94.2 % (88.8; 97.5) overall diagnoses 255/273 = 93.4 % (89.8; 96.1) |
n/r | n/r | ||
Fariña [40] | 2002 | 81 | 64/81 = 79.0 % (68.5; 87.3) |
n/r | n/r | n/r | n/r | n/r | ||
Fariña [41] | 1998 | 130 (-29)1 | 120/130 = 92.3 % (86.3; 96.3) |
n/r | n/r | n/r | n/r | n/r | ||
Without | Fan [51] | 2010 | 16 | 15/16 = 93.8 % (69.8; 99.8) |
based on 18 cases “90 %” (65.3; 98.6) |
n/r | n/r | n/r | n/r | |
Cacchione [52] | 2001 | 7 | combined with review of patients’ hospital records ῍100 %” (59.0; 100) | n/r | n/r | n/r | n/r | n/r | ||
Huston [42] | 1996 | 20(-1 or more)1 | 12/20 = 60 % (36.1; 80.9) |
11/19 = 57.9 % (33.5; 79.8) |
new major diagnoses 20/24 = 83.3 % (62.6; 95.3) |
new major diagnoses 12/16 = 75 % (47.6; 92.7) |
cultures 39/46 = 84.8 % (71.1; 93.7) |
cultures 10/15 = 66.6 % (38.4; 88.2) |
1Some cases should still be excluded, for these deceased were younger than 18 years of age or died from an unnatural cause of death
2Originally reported as being agreement
* Some of the included cases seem to overlap